Skip to main content

You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

Association of Australian Medical Research Institutes Limited
2020 AAMRI Convention
Association of Australian Medical Research Institutes Limited
Home
User Headshot

Rob Merriel

Chief Financial Officer - Hudson Institute of Medical Research

Rating


Professional Bio

Rob is a Certified Practicing Accountant with more than 35 years’ experience working in medical research (Baker and Hudson Institute), healthcare (Melbourne Health and Monash Health) and commercial organisations (Pacific Dunlop and Deloitte Consulting). The current Chief Financial Officer and Chief Commercialisation Officer of Hudson Institute, He is currently on the Boards of ASX Listed cancer therapeutics developer Invion Limited (ASX: IVX) and two biotechnology start-up companies, he has been a Director of two Venture Capital Funds and a Director and Company Secretary of several biotechnology focused medical research institute spin off companies. Rob has many years’ experience on Finance, Audit and Risk Management Committees for NFPs and biotechnology companies. 

Rob's Presentations

View Program
10 December 2020 12:00 pm
Room 1
Financial resilience during turbulent times